Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 22, 2020

SELL
$2.68 - $4.85 $5,360 - $9,700
-2,000 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$5.1 - $6.71 $10,200 - $13,420
2,000 New
2,000 $13,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $313M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.